ANTM:NYE-Anthem, Inc (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 395.59

Change

+0.30 (+0.08)%

Market Cap

USD 96.38B

Volume

0.75M

Avg Analyst Target

USD 427.05 (+7.95%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2020, it served 43 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-08-04 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

-0.36 (-0.09%)

USD398.15B 27.87 17.37
CVS CVS Health Corporation

-2.45 (-2.92%)

USD110.59B 14.96 10.66
CI Cigna Corporation

-2.48 (-1.06%)

USD80.15B 10.06 N/A
HUM Humana Inc

+0.72 (+0.17%)

USD54.68B 22.51 N/A
CNC Centene Corporation

-0.24 (-0.35%)

USD40.42B 56.83 14.84
MOH Molina Healthcare, Inc

+1.34 (+0.48%)

USD16.20B 25.96 9.55
GTS Triple-S Management Corporatio..

+0.19 (+0.78%)

USD0.58B 4.88 N/A

ETFs Containing ANTM

Symbol Name Weight Mer Price(Change) Market Cap
BIV Vanguard Intermediate-Ter.. 0.00 % 0.05 %

-0.07 (-0.08%)

USD39.02B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

N/A

N/A
IBCZ:XETRA iShares IV Public Limited.. 0.00 % 0.50 %

+0.02 (+0.26%)

USD0.57B
IBCY:XETRA iShares IV Public Limited.. 0.00 % 0.35 %

+0.02 (+0.22%)

USD0.12B
IS07:F iShares IV Public Limited.. 0.00 % 0.55 %

+0.01 (+0.12%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.50 %

+0.02 (+0.28%)

USD0.57B
IBCY:F iShares IV Public Limited.. 0.00 % 0.35 %

+0.02 (+0.21%)

USD0.12B
UFSD:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

N/A

USD1.33M
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.50 %

+0.02 (+0.21%)

USD0.57B
IFSU:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.03 (+0.30%)

USD0.12B
FSWD:LSE iShares IV Public Limited.. 0.00 % 0.50 %

-0.88 (-0.13%)

N/A
FSUS:LSE iShares IV Public Limited.. 0.00 % 0.35 %

+1.75 (+0.24%)

USD0.12B
ACWF iShares MSCI Global Multi.. 0.00 % 0.35 %

-0.11 (-0.28%)

USD0.12B
HUL-U:CA Harvest US Equity Plus In.. 0.00 % 2.58 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

+0.10 (+0.83%)

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

+0.97 (+2.11%)

USD0.05B
FHH:CA First Trust AlphaDEX U.S... 0.00 % 0.77 %

N/A

USD0.02B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

+0.06 (+0.50%)

USD0.08B
HUL:CA Harvest US Equity Plus In.. 0.00 % 2.58 %

+0.09 (+0.91%)

USD7.80M
HHL:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

-0.06 (-0.69%)

USD0.33B
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

+0.53 (+0.62%)

USD0.57B
XFS:CA iShares MSCI Multifactor .. 0.00 % 0.51 %

N/A

USD0.07B
XFA:CA iShares MSCI Multifactor .. 0.00 % 0.51 %

N/A

USD0.01B
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

-0.68 (-1.62%)

USD0.13B
PBI Pitney Bowes Inc 0.00 % 0.00 %

-0.20 (-2.57%)

USD1.36B
LRGF iShares MSCI USA Multifac.. 0.00 % 0.20 %

-0.31 (-0.70%)

USD1.04B
JHMH John Hancock Multifactor .. 0.00 % 0.40 %

-0.08 (-0.17%)

USD0.05B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

-1.47 (-0.54%)

USD1.44B
FXH First Trust Health Care A.. 0.00 % 0.61 %

+0.87 (+0.71%)

USD1.52B
FTLS First Trust Long/Short Eq.. 0.00 % 1.55 %

-0.32 (-0.65%)

USD0.37B
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.01 (+0.08%)

USD6.67M

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.20% 88% B+ 77% C+
Dividend Return 0.70% 40% F 25% F
Total Return 23.91% 88% B+ 76% C
Trailing 12 Months  
Capital Gain 43.51% 88% B+ 72% C-
Dividend Return 1.51% 60% D- 25% F
Total Return 45.02% 100% A+ 70% C-
Trailing 5 Years  
Capital Gain 209.39% 75% C 93% A
Dividend Return 12.72% 80% B- 46% F
Total Return 222.11% 75% C 93% A
Average Annual (5 Year Horizon)  
Capital Gain 22.94% 63% D 85% B
Dividend Return 1.44% 67% D+ 36% F
Total Return 24.37% 63% D 85% B
Risk Return Profile  
Volatility (Standard Deviation) 22.90% 50% F 48% F
Risk Adjusted Return 106.45% 50% F 93% A
Market Capitalization 96.38B 75% C 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.39 50% F 34% F
Price/Book Ratio 2.68 50% F 38% F
Price / Cash Flow Ratio 9.02 38% F 47% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 12.20% 38% F 65% D
Return on Invested Capital -3.16% 13% F 19% F
Return on Assets 5.13% 63% D 76% C
Debt to Equity Ratio 58.24% 63% D 58% F
Technical Ratios  
Short Ratio 2.15 63% D 49% F
Short Percent 1.07% 63% D 76% C
Beta 1.05 13% F 52% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.